Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Degenerative Arthritis
Interventions
BIOLOGICAL

TissueGene-C

TissueGene-C at 1.8 x 10\^7 cells

DRUG

Placebo

Placebo control(Normal Saline)

Trial Locations (12)

361-711

Chungbuk National University Hospital, Cheongju-si

700-721

Kyungpook National Univ. Hospital, Daegu

400-711

Inha University Hospital, Incheon

561-712

Chonbuk National University Hospital, Jeonju

100-032

Inje University Seoul Paik Hospital, Seoul

110-744

Seoul National University Hospital, Seoul

133-791

Hanyang University Medical Center, Seoul

135-710

Samsung Medical Center, Seoul

137-701

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

138-736

ASAN Medical Center, Seoul

158-710

Ewha Womans University Mokdong Hospital, Seoul

682-714

Ulsan University Hospital, Ulsan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Kolon Life Science

INDUSTRY